These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30198876)

  • 1. "Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic.
    Gordish-Dressman H; Willmann R; Dalle Pazze L; Kreibich A; van Putten M; Heydemann A; Bogdanik L; Lutz C; Davies K; Demonbreun AR; Duan D; Elsey D; Fukada SI; Girgenrath M; Patrick Gonzalez J; Grounds MD; Nichols A; Partridge T; Passini M; Sanarica F; Schnell FJ; Wells DJ; Yokota T; Young CS; Zhong Z; Spurney C; Spencer M; De Luca A; Nagaraju K; Aartsma-Rus A
    J Neuromuscul Dis; 2018; 5(4):407-417. PubMed ID: 30198876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
    Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
    Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural disease history of the D2
    van Putten M; Putker K; Overzier M; Adamzek WA; Pasteuning-Vuhman S; Plomp JJ; Aartsma-Rus A
    FASEB J; 2019 Jul; 33(7):8110-8124. PubMed ID: 30933664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of genetic background on the dystrophic phenotype in mdx mice.
    Coley WD; Bogdanik L; Vila MC; Yu Q; Van Der Meulen JH; Rayavarapu S; Novak JS; Nearing M; Quinn JL; Saunders A; Dolan C; Andrews W; Lammert C; Austin A; Partridge TA; Cox GA; Lutz C; Nagaraju K
    Hum Mol Genet; 2016 Jan; 25(1):130-45. PubMed ID: 26566673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
    Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
    J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Alzheimer's disease-like neuropathology in Duchenne's muscular dystrophy using the DBA/2J mdx mouse model.
    Hayward GC; Caceres D; Copeland EN; Baranowski BJ; Mohammad A; Whitley KC; Fajardo VA; MacPherson REK
    FEBS Open Bio; 2022 Jan; 12(1):154-162. PubMed ID: 34668666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystrophic Dmd
    Krishnan VS; Thanigaiarasu LP; White R; Crew R; Larcher T; Le Guiner C; Grounds MD
    Mol Cell Neurosci; 2020 Oct; 108():103549. PubMed ID: 32890728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenine metabolism is altered in mdx mice: a potential muscle to brain connection.
    Copeland EN; Watson CJF; Whitley KC; Baranowski BJ; Kurgan N; MacNeil AJ; MacPherson REK; Fajardo VA; Allison DJ
    Exp Physiol; 2022 Sep; 107(9):1029-1036. PubMed ID: 35912981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
    Bozycki L; Łukasiewicz K; Matryba P; Pikula S
    Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of increased S100β and Tau5 proteins in dystrophic nerves of two mdx mouse models for Duchenne muscular dystrophy.
    Krishnan VS; Aartsma-Rus A; Overzier M; Lutz C; Bogdanik L; Grounds MD
    Mol Cell Neurosci; 2020 Jun; 105():103484. PubMed ID: 32240725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.
    Kornegay JN; Spurney CF; Nghiem PP; Brinkmeyer-Langford CL; Hoffman EP; Nagaraju K
    ILAR J; 2014; 55(1):119-49. PubMed ID: 24936034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.
    Rodrigues M; Echigoya Y; Fukada SI; Yokota T
    J Neuromuscul Dis; 2016 Mar; 3(1):29-48. PubMed ID: 27854202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoA/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy.
    Fernández-Simón E; Suárez-Calvet X; Carrasco-Rozas A; Piñol-Jurado P; López-Fernández S; Pons G; Bech Serra JJ; de la Torre C; de Luna N; Gallardo E; Díaz-Manera J
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1373-1384. PubMed ID: 35132805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal synaptic and membrane function in the DBA/2J-mdx mouse model of Duchenne muscular dystrophy.
    Bianchi R; Eilers W; Pellati F; Corsi L; Foster H; Foster K; Tamagnini F
    Mol Cell Neurosci; 2020 Apr; 104():103482. PubMed ID: 32171922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved Left Ventricular Function despite Myocardial Fibrosis and Myopathy in the Dystrophin-Deficient D2.B10-Dmd
    Hayes HM; Angerosa J; Piers AT; White JD; Koleff J; Thurgood M; Moody J; Cheung MM; Pepe S
    Oxid Med Cell Longev; 2022; 2022():5362115. PubMed ID: 35340200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.